MetLife director Kennard receives 544 shares as pay

The award was part of director retainer fees paid in stock, with receipt deferred under the MetLife Deferred Compensation Plan for Non-Management Directors.

Rhea-AI Filing Summary

MetLife, Inc. director William E. Kennard acquired 544 common shares on October 1, 2026, as part of non-management director retainer fees paid in stock; the reported transaction price was $94.35 per share. Kennard elected to defer receipt under the MetLife Deferred Compensation Plan for Non-Management Directors. His reported direct holdings following the award were 48,248 shares. A separate holding entry lists 10 shares held by the MetLife Policyholder Trust for allocation to eligible policyholders.

Insider Trade Summary

Grant/Award: 544 shares

Grant/Award 2 txns

Insider Kennard William E

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	544	$94.35	$51K
holding	Common Stock F2	--	--	--

Holdings After Transaction: Common Stock — 48,248 shares (Direct); Common Stock — 10 shares (Indirect, By the MetLife Policyholder Trust)

Footnotes (2)

1. F1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
2. F2. Shares held in trust under the MetLife Policyholder Trust established to hold shares of common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.

Key Figures

Common shares acquired: 544 shares Reported transaction price: $94.35 per share Direct shares following award: 48,248 shares +1 more

4 metrics

Common shares acquired 544 shares Director compensation award on October 1, 2026

Reported transaction price $94.35 per share Common shares acquired on October 1, 2026

Direct shares following award 48,248 shares William E. Kennard’s reported direct holdings

Shares held by MetLife Policyholder Trust 10 shares Holding entry dated October 1, 2026

Key Terms

MetLife Deferred Compensation Plan for Non-Management Directors, non-management director retainer fees, MetLife Policyholder Trust

3 terms

MetLife Deferred Compensation Plan for Non-Management Directors financial

"defer receipt of these shares under the MetLife Deferred Compensation Plan"

non-management director retainer fees financial

"a portion of non-management director retainer fees"

MetLife Policyholder Trust financial

"Shares held in trust under the MetLife Policyholder Trust"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MET shares did William E. Kennard receive, and what was the reported price?

William E. Kennard received 544 MetLife common shares on October 1, 2026, reported at $94.35 per share. The shares represented part of his non-management director retainer fees, which are paid in stock.

How many MET shares did William E. Kennard hold after the award?

After the award, William E. Kennard reported direct holdings of 48,248 MetLife common shares. A separate holding entry lists 10 shares held by the MetLife Policyholder Trust, established to hold shares allocated to eligible policyholders of a MetLife subsidiary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/05/2026 - 04:04 PM Accepted by SEC EDGAR 10/05/2026 - 04:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kennard William E

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/01/2026		A(1)		544	A	$94.35	48,248	D
Common Stock								10	I	By the MetLife Policyholder Trust(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

2. Shares held in trust under the MetLife Policyholder Trust established to hold shares of common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	10/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)